| +0.60 / +0.67%|
The 2 analysts offering 12-month price forecasts for Furiex Pharmaceuticals Inc have a median target of 147.00, with a high estimate of 157.00 and a low estimate of 137.00. The median estimate represents a +62.41% increase from the last price of 90.51.
The current consensus among 2 polled investment analysts is to Buy stock in Furiex Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.